Cost-effectiveness of adjunctive eptifibatide in patients undergoing coronary stenting in Germany
Year of publication: |
2012
|
---|---|
Authors: | Dewilde, Sarah ; Brüggenjürgen, Bernd ; Nienaber, Christoph ; Senges, Jochen ; Welte, Robert ; Willich, Stefan |
Published in: |
The European Journal of Health Economics. - Springer. - Vol. 13.2012, 4, p. 381-391
|
Publisher: |
Springer |
Subject: | Eptifibatide | GPIIb/IIIa inhibitor | Cardiovascular | PCI | Extrapolation | Cost-effectiveness |
-
Plosker, Greg L., (2003)
-
Spotlight on Eptifibatide in Percutaneous Coronary Intervention and Acute Coronary Syndromes
Plosker, Greg L., (2004)
-
Components and possible determinants of decrease in Russian mortality in 2004-2010
Shkolnikov, Vladimir M., (2013)
- More ...
-
Cost-effectiveness of adjunctive eptifibatide in patients undergoing coronary stenting in Germany
Dewilde, Sarah, (2012)
-
Economic and Human Costs of Restless Legs Syndrome
Reinhold, Thomas, (2009)
-
Cost Effectiveness of Antiarrhythmic Medications in Patients Suffering from Atrial Fibrillation
Brüggenjürgen, Bernd, (2013)
- More ...